[Pharm-policy] USTR out-of-cycle reviews

[Mike Palmedo]

http://www.ustr.gov/releases/2001/01/01-11.html

Here's a USTR press release on their 301 out-of-cycle reviews.  PhRMA
had asked the USTR to put the United Arab Emirates on the list, but the
UAE "recieved no listing."  Here's the UAE section of the release...

The U.S. has been discussing with the U.A.E. for some time the problem
of unauthorized copies of patented pharmaceuticals. Last April, the
U.A.E. agreed to prevent the marketing of unauthorized copycat drugs.
Unfortunately, marketing approval for some copycat drugs was granted
nevertheless. However, recent consultations between our two governments
resulted in assurances from the Government of the U.A.E. that it will
reverse any marketing approvals granted in violation of last year's
agreement. "We appreciate the renewed promise by the U.A.E. to respect
patent rights in a manner consistent with the WTO TRIPS Agreement,"
Ambassador Barshefsky said. "We plan to continuously monitor over the
coming weeks the U.A.E.'s fulfillment of its recent commitments in this
regard and will take any further steps that may be warranted."